Furthermore, it has been reported that DXM induces NAFLD through promoting FASN and CD36 expression, hepatic DNL pathway, FAs transport, and lipid accumulation (Woods et al. 2015). The gene discussed is CD36; the disease is metabolic dysfunction-associated steatotic liver disease.